{"cluster": 47, "subcluster": 0, "abstract_summ": "Observing such a high prevalence in COVID-infected patients was somehow unexpected since the 30% prevalence of invasive aspergillosis in influenza patients has been attributed to the action of oseltamivir on anti-Aspergillus immunity.We classified the patients based on the recently published study on invasive aspergillosis in influenza patients in your journal (Schauwvlinghe et al., 2018.) and found 33% of our COVID-19 patients with putative invasive pulmonary aspergillosis.FilmArray had a higher diagnostic yield than culture for ICU COVID-19 patients with suspected secondary pneumonias.It can be a diagnostic challenge to identify COVID-19 patients without bacterial co-infection in whom antibiotics can be safely stopped.This message is major, given the high mortality rate of COVID-19 patients in the ICU.Aspergillus is a mold that may lead to different clinical pictures, from allergic to invasive disease, depending on the patient\u2019s immune status and structural lung diseases.", "title_summ": "Organisms causing secondary pneumonias in COVID-19 patients at 5 UK ICUs as detected with the FilmArray testDo COVID-19 patients admitted to the ICU require anti-Pneumocystis jirovecii prophylaxis?Routine measurement of serum procalcitonin allows antibiotics to be safely withheld in patients admitted to hospital with SARS-CoV-2 infection.Influenza-associated aspergillosis in critically-ill patients\u2014a retrospective bicentric cohort studyCOVID-19 associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.High prevalence of putative invasive pulmonary aspergillosis in critically ill COVID-19 patientsPulmonary Aspergillosis: An Evolving Challenge for Diagnosis and TreatmentReview of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion", "title_abstract_phrases": "Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinionPURPOSE: Invasive pulmonary aspergillosis is increasingly reported in patients with influenza admitted to the intensive care unit (ICU).We classified the patients based on the recently published study on invasive aspergillosis in influenza patients in your journal (Schauwvlinghe et al., 2018.) and found 33% of our COVID-19 patients with putative invasive pulmonary aspergillosis.Observing such a high prevalence in COVID-infected patients was somehow unexpected since the 30% prevalence of invasive aspergillosis in influenza patients has been attributed to the action of oseltamivir on anti-Aspergillus immunity.FilmArray had a higher diagnostic yield than culture for ICU COVID-19 patients with suspected secondary pneumonias.This message is major, given the high mortality rate of COVID-19 patients in the ICU.Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and TreatmentAspergillus is a mold that may lead to different clinical pictures, from allergic to invasive disease, depending on the patient\u2019s immune status and structural lung diseases."}